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Persistence, more recently termed the chlamydial stress response, is a viable but noninfectious state constituting a divergence from the characteristic chlamydial biphasic developmental cycle. Damage/danger associated molecular patterns (DAMPs) are normal intracellular components or metabolites that, when released from cells, signal cellular damage/
lysis. Purine metabolite DAMPs, including extracellular ATP and adenosine, inhibit chlamydial development in a species-specific manner. Viral co-infection has been shown to
reversibly abrogate Chlamydia inclusion development, suggesting persistence/chlamydial
stress. Because viral infection can cause host cell DAMP release, we hypothesized DAMPs
may influence chlamydial development. Therefore, we examined the effect of extracellular
ATP, adenosine, and cyclic AMP exposure, at 0 and 14 hours post infection, on C. pecorum
and C. trachomatis serovar E development. In the absence of de novo host protein synthesis, exposure to DAMPs immediately post or at 14 hours post infection reduced inclusion
size; however, the effect was less robust upon 14 hours post infection exposure. Additionally, upon exposure to DAMPs immediately post infection, bacteria per inclusion and subsequent infectivity were reduced in both Chlamydia species. These effects were reversible,
and C. pecorum exhibited more pronounced recovery from DAMP exposure. Aberrant bodies, typical in virus-induced chlamydial persistence, were absent upon DAMP exposure. In
the presence of de novo host protein synthesis, exposure to DAMPs immediately post infection reduced inclusion size, but only variably modulated chlamydial infectivity. Because
chlamydial infection and other infections may increase local DAMP concentrations, DAMPs
may influence Chlamydia infection in vivo, particularly in the context of poly-microbial
infections.
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Introduction
The Chlamydiaceae are a genus of Gram-negative, obligate intracellular bacterial pathogens
that cause a spectrum of diseases in both humans and agriculturally important animals. C.
pecorum infection, for example, causes clinical manifestations in swine ranging from conjunctivitis to abortion [1]. C. trachomatis infection in humans can cause medically important conditions, such as trachoma, pelvic inflammatory disease, and infertility. Though chlamydial
infections can cause acute diseases, they are most associated with chronic inflammation resulting in significant host tissue damage [2]. The chlamydiae also share a complex developmental
cycle. The infectious form (the elementary body or EB), binds to and enters the host cell. After
host cell entry, the EB transitions into the more metabolically active, replicative developmental
form (the reticulate body or RB). The RB then grow and divide within a cytoplasmic, membrane-bound inclusion. After several rounds of division, RB convert back into infectious EB,
which are released from the host cell [3]. A third stage, historically termed persistence or more
recently the chlamydial stress response, is defined as a developmental stage in which the organisms are viable but non-infectious. Persistent/stressed RB are enlarged, irregularly shaped and
non-dividing; these altered developmental forms are sometimes called aberrant bodies (AB).
The persistence/stress response is reversible—when the stressor is removed, the chlamydiae
resume normal, productive development. A variety of stressors induce chlamydial persistence/
stress in culture: these include IFN-γ exposure; glucose, iron and amino acid deprivation; and
host cell co-infection with herpes simplex virus type 2 [4], Human Herpes Virus 6 [5], and the
coronavirus porcine epidemic diarrhea virus (PEDV) [6,7].
Both pathogen infection and sterile trauma can promote release of damage/danger associated molecular patterns (DAMPs) from mammalian cells/tissues. Typically, DAMPs are normal intracellular components or metabolites, the release of which into the extracellular milieu
indicates cellular damage or lysis. Once in the extracellular environment, DAMPs bind signaling receptors on mammalian cells and initiate specific responses that promote local inflammation and wound healing. Known DAMPs include heat shock proteins, high mobility group
box 1 protein (HMGB1), uric acid, and purine metabolites (reviewed in [8]) [9]. Extracellular
ATP (ATPe) and adenosine (ADO) are two well studied DAMPs, the binding of which to purinergic receptors initiates components of the mammalian defense against intracellular pathogens (reviewed in [10]). Purinergic receptor activation is known to limit chlamydial
development in a host cell- and chlamydial species-specific manner. For example, exposure of
C. caviae-infected mouse J774 macrophages to ATPe reduces infectious titer by >50% [11].
ATPe-exposure also restricts C. muridarum development in J774 cells by promoting inclusionlysosomal fusion. However, ATPe-exposure does not kill chlamydiae in peritoneal macrophages elicited from P2X7 receptor knock-out mice, demonstrating a requirement for this
receptor. ATPe reduces production of C. muridarum EB in J774 cells [12] and a similar reduction is observed in HeLa cells [13]. Furthermore, C. muridarum infectious burden in P2X7
receptor-deficient mice is 10 times higher than that of their wild-type counterparts [13]. These
data suggest that ATPe may play a significant anti-chlamydial role in vivo, as well as in vitro.
Extracellular ADO-exposure also reduces infectious EB production by both C. trachomatis L2
and serovar D in HeLa cells, primarily by signaling through the A2b receptor. Though recovery
of serovar D was not tested, L2 recovered infectivity post-termination of ADO-exposure. Thus,
the authors concluded that ADO-exposure induces the C. trachomatis L2 persistence/stress
response [14].
As stated previously, host cell co-infection with PEDV abrogates productive development of
both C. pecorum and C. abortus [6]. Furthermore, this effect is reversible and results in AB formation, suggesting that PEDV co-infection induces the chlamydial persistence/stress response.
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Neither UV inactivation of the virus nor inhibition of viral protein synthesis with cycloheximide ablates this response [7], suggesting that either a virion component (such as an envelope
glycoprotein or genomic RNA) or a pre-synthesized host cellular component (such as a cytokine or DAMP) mediates this effect. Viruses induce DAMP release from infected host cells and
are, in turn, affected by DAMP-induced responses. For example, infection with the Arterivirus
porcine reproductive and respiratory syndrome virus (PRRSV) releases the DAMP HMGB1
from infected host cells, resulting in macrophage expression of pro-inflammatory cytokines
[15]. Undamaged Influenza A-infected cells release the DAMP S100A9, which activates host
inflammatory responses [16]. Influenza A-induced extracellular ATP release may also up-regulate Streptococcus pneumoniae virulence genes–providing one possible explanation for the
increased lethality of post-influenza pneumococcal pneumonia [17]. Finally, extracellular ATP
is both released from Human Immunodeficiency Virus (HIV)-infected macrophages [18] and
facilitates HIV entry into new host cells [19]. Therefore, we hypothesized that release of
DAMPs from PEDV-infected cells may influence the C. pecorum developmental cycle. As a
first step in testing this hypothesis, we examined the effect of extracellular ATP and adenosine
(ADO) on C. pecorum development.
The aim of this study was to investigate the effect of DAMPs on C. pecorum inclusion development. Exposure of Chlamydia-infected cells to DAMPs reversibly reduced inclusion size,
bacteria per inclusion and subsequent chlamydial infectivity upon re-infection of host cells.
Notably, aberrant bodies, characteristic of PEDV-induced C. pecorum persistence, were absent
upon DAMP exposure. Parallel evaluation of two chlamydial species, C. pecorum and C. trachomatis serovar E, demonstrated that DAMPs exert their effect in a species-specific manner.
Comparison of DAMP exposure beginning at 0 hours versus 14 hours post infection showed
that similar reduction of inclusions size and lack of induction of aberrant body formation
occur independent of the time of initiation of DAMP exposure. This study, to our knowledge,
represents the first evaluation of the effects of DAMPs on C. pecorum inclusion development,
and as such provides novel information regarding the host/pathogen interactions of this
important, though less frequently studied, chlamydial species.

Materials and Methods
Host cells and media
HeLa cells (human cervical adenocarcinoma epithelial cells, CCL-2, American Type Culture
Collection, Manassas, VA, USA; kindly provided by Christian Blenn, Institute of Veterinary
Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland) were cultured at
37°C and 5% CO2 in growth medium for cell propagation and maintenance. Growth medium
consisted of Minimal Essential Medium (MEM) with Earle’s salts, 25 mM HEPES, without
L-Glutamine (GIBCO, Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal calf
serum (FCS, BioConcept, Allschwil, Switzerland), 4 mM GlutaMAX-I (200 mM, GIBCO), 1%
MEM Non-Essential Amino Acids (100x, GIBCO) and 0.2 mg/ml gentamycin (50 mg/ml,
GIBCO). For use in experiments, cells were seeded in 24-well plates (Techno Plastic Products
AG (TPP), Trasadingen, Switzerland) at a density of 3x105 per well in 1 mL growth medium
without gentamycin on 13 mm diameter glass coverslips (Sterilin Limited; Thermo Fisher Scientific, Cambridge, UK) for immunofluorescence (IF) microscopy or transmission electron
microscopy (TEM), or directly in the 24-well plates for titration by sub-passage. Infection
medium, used for inoculating cells with Chlamydia, consisted of growth medium components
except FCS and gentamycin. Incubation medium, used to replace infection medium after
infection with Chlamydia, consisted of growth medium components except gentamycin,

PLOS ONE | DOI:10.1371/journal.pone.0134943 August 6, 2015

3 / 30

DAMPs Modulate Chlamydia Inclusion Development

supplemented with 1 μg/ml cycloheximide (Sigma-Aldrich, St. Louis, MO, USA) immediately
before use. In some experiments, growth medium without cycloheximide was used.

Reagents
The following reagents were solubilized in sterile distilled H2O, stored at -20°C, and thawed
immediately before use: adenosine (ADO, Abcam Biochemicals, Cambridge, UK), erythro-9(2-Hydroxy-3-nonyl)-adenine hydrochloride (EHNA, Sigma-Aldrich), adenosine-5-triphosphate disodium salt (ATP, Sigma-Aldrich), apyrase (Sigma-Aldrich), adenosine-3’,5’-cyclic
monophosphate (cAMP, Sigma-Aldrich), 8-Bromo-cAMP (8BrcAMP, Abcam Biochemicals).

Chlamydial strains
C. pecorum 1710S (isolate from a swine abortion) was kindly provided by Prof. J. Storz, Baton
Rouge, LA, USA [20]. The isolate of the C. trachomatis strain was originally obtained from S. P.
Wang and C. C. Kuo (University of Washington, Seattle, WA, USA) [21]. C. pecorum and C.
trachomatis were propagated in HeLa cells, and crude stocks were suspended in SPG medium
and stored at -80°C. SPG medium consisted of 218 mM sucrose (Sigma-Aldrich), 3.76 mM
KH2PO4 (Sigma-Aldrich), 7.1 mM K2HPO4 (Merck Eurolab AG, Dietlikon, Switzerland) and
5 mM GlutaMAX-100 (GIBCO).

Study design, infection and exposure of host cells to DAMPs
HeLa cells, cultivated overnight in 24-well plates, were infected with either C. pecorum or C.
trachomatis at 1 multiplicity of infection (MOI) in 1 ml infection medium and centrifuged for
1 hour (h) at 1000 g and 25°C. After centrifugation, infection medium was replaced by incubation medium and cultures were incubated at 37°C and 5% CO2 as previously described [6]. The
crude stocks used resulted in approximate infection rates of 40% for C. pecorum and 20% for C.
trachomatis; this corresponded to approximately 107 recoverable inclusion forming units
(IFU) per well for both C. pecorum and C. trachomatis diluent-exposed infected cells after 35
or 39 hours of incubation, respectively.
The effect on Chlamydia inclusion formation of various danger associated molecular patterns, DAMPs [cAMP, ATP, ADO], and analogues [8BrcAMP] or modulators [EHNA, apyrase] of these DAMPs, was determined by adding reagents to the incubation medium of
infected cells at T0, immediately after infection (Fig 1A), or at T14, 14 hours after infection (Fig
1B). In a single experiment, the effect of DAMPs added at T0 was evaluated in parallel with and
without cycloheximide supplementation of the incubation medium. In some experiments, apyrase was added to abrogate the activity of ATP. In these cases, apyrase was added to the incubation medium and the cultures incubated at 37°C and 5% CO2 for 15 minutes prior to the
addition of ATP. For EHNA/ADO exposure, both reagents were added to the incubation
medium together at the indicated times [T0 or T14]. Diluent alone, sterile distilled H2O, served
as mock exposure controls. In preliminary experiments for this study, in HeLa cells, C. pecorum
inclusions and host cells begin to burst earlier than C. trachomatis inclusions and host cells.
Chlamydia-infected cells were thus incubated until mature inclusions could be evaluated, but
bursting of inclusions and cells was not evident: 39 h post infection (hpi) for C. trachomatisinfected cells, as previously reported [22], and 35 hpi for C. pecorum-infected cells, as determined by preliminary experiments (Fig 2). In continued exposure and recovery experiments,
incubation medium was changed and cells were incubated for a further 24 hours (Fig 1C).
Samples were collected at the indicated times (Fig 1) and processed for further analysis as
previously described [6]. For IF microscopy, cells were fixed with absolute methanol (-20°C)
for 10 minutes; for TEM cells were fixed with 2.5% glutaraldehyde (Electron Microscopy

PLOS ONE | DOI:10.1371/journal.pone.0134943 August 6, 2015

4 / 30

DAMPs Modulate Chlamydia Inclusion Development

Fig 1. Study Design. (A) Diagram illustrating infection and exposure beginning at T0, immediately after infection. Host cells were infected with Chlamydia
(C.) pecorum or C. trachomatis serovar E, exposed to DAMPs in incubation medium, and incubated for 35 or 39 hours, at which time samples were collected
for analysis. (B) DAMP exposure beginning at T14, 14 hours after infection. DAMPs were added directly to incubation medium. (C) DAMP exposure beginning
at T0, followed by 35/39-hour incubation, media change for continued DAMP exposure or recovery in the absence of DAMPs, and 24 hours of additional
incubation.
doi:10.1371/journal.pone.0134943.g001

Sciences, Ft. Washington, USA) for 1 h and embedded in epoxy resin (Fluka; Sigma-Aldrich)
by routine methods; for titration by sub-passage infected monolayers were scraped into 1 ml of
fresh infection medium and stored at -80°C. For continued exposure or recovery (Fig 1C) sample collection for titration by sub-passage culture supernatant was collected (total volume per
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Fig 2. Determination of optimal DAMP concentrations for inhibition of C. pecorum inclusion
development. HeLa cells were infected with C. pecorum and exposed to the DAMPs (A) cAMP, (B) ATP, or
(C) EHNA/ADO (ADO concentration varies, EHNA = 25 μM) in incubation medium immediately after
infection. Cells were incubated for 35 hours, fixed and labeled with anti-LPS and DAPI, and inclusion size
was determined (mean ± SD; ** p  0.0001, *p  0.01, t test; n = 50 inclusions per coverslip from a single
experiment). Arrows indicate concentrations selected for use in the study.
doi:10.1371/journal.pone.0134943.g002

well = 1 ml), infected monolayers were scraped into 1 ml of fresh infection medium, and supernatant and scraped cells were pooled before storage at -80°C.

IF microscopy
C. trachomatis and C. pecorum inclusions were visualized using a Chlamydiaceae family-specific mouse monoclonal antibody directed against the chlamydial lipopolysaccharide (LPS,
Clone ACI-P, 1:200; Progen, Heidelberg, Germany) and 1:500 diluted Alexa Fluor 488-conjugated secondary goat anti-mouse antibody (Molecular Probes, Eugene, OR, USA). Host and
chlamydial DNA were labeled using 1 μg/ml 4’, 6-diamidino-2’-phenylindole dihydrochloride
(DAPI, Molecular Probes). Coverslips were mounted with FluoreGuard mounting medium
(Hard Set; ScyTek Laboratories Inc., Logan, UT, USA) on glass slides and evaluated using a
Leica DMLB fluorescence microscope (Leica Microsystems, Wetzlar, Germany) under oil
immersion at 1000x magnification with a 1006 objective (PL FLUOTAR 100x/1.30, OIL,
‘/0.17/D, Leica Microsystems) and a 106 ocular objective (Leica L-Plan 10x/ 25 M, Leica
Microsystems).
To determine percent of cells infected (inclusions per nucleus) and mean number of nuclei
per field (to evaluate possible cell loss from the monolayer), HeLa nuclei and corresponding
chlamydial inclusions in each of 8 randomly selected microscopic fields were counted per condition (at least 200 HeLa nuclei per condition). To determine mean inclusion size, 50 randomly
selected inclusions were examined per condition and area in μm2 was calculated using BonTec
measuring and archiving software (BonTec, Bonn, Germany). Representative microscopic
images were captured using BonTec software (BonTec) and a UI-2250SE-C-HQ camera (uEye,
IDS Imaging Development Systems GmbH, Obersulm, Germany).

Chlamydial titration by sub-passage
HeLa cells were grown on glass coverslips as described above. Samples were thawed and sonicated on ice for 5 minutes (Branson Sonifier 250; Branson Ultrasonics, Danbury, CT, USA).
Sonicated samples were serially diluted in infection medium and infection of the prepared
HeLa cells, centrifugation, medium replacement with incubation medium, and incubation was
carried out as described for infection of host cells. Fixation and immunostaining was performed as described for IF microscopy. The number of inclusions in 30 random microscopic
fields for duplicate coverslips per condition was determined using a Leica fluorescence microscope at 200x magnification with a 206 objective (PL FLUOTAR 20x/0.50 PH 2, ‘/0.17/B) and a
106 ocular objective (Leica L-Plan 10x/25 M, Leica Microsystems). Inclusion forming units
(IFU) per ml of undiluted inoculum was then calculated according to previously published
methods [4].

TEM
Ultrathin (80 nm) sections were mounted on gold grids (Merck), contrasted with uranyl acetate
dehydrate (Fluka; Sigma-Aldrich) and lead citrate (Merck). The sections were evaluated using
a Philips CM10 electron microscope (Software release version 5.1; FEI Company, Hillsboro,
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OR, USA) and imaged using a Gatan Orius SC 1000 CCD Camera with software version Digital
Micrograph 2.30 (Gatan Inc., Warrendale, PA, USA). Images were analyzed using Photoshop
CS6 software (Adobe Systems Incorporated, San Jose, CA, USA). To determine mean number
of bacteria per inclusion, the total number of bacteria in ten inclusions per condition was
counted. Bacterial morphology was determined as previously described [22]: EB (dark, 0.25–
0.5 μm), IB (dark center and pale periphery), RB (pale, 0.5–1 μm) and AB (pale, <2 μm).

Statistical analysis
Statistical analyses were performed using Microsoft Excel. Significance of the difference of
means was determined by unpaired t test and p values of <0.05 were considered significant. P
values were confirmed using the GraphPad QuickCalcs Web site: http://www.graphpad.com/
quickcalcs/ttest1/ (accessed June 2014). Unless stated otherwise, results are displayed as means,
+/- standard deviation, of the results from three independent experiments.

Results
cAMP, ATP and EHNA/ADO inhibit Chlamydia inclusion development
To characterize the effect of the damage/danger associated molecular patterns (DAMPs) extracellular ATP and adenosine (ADO) on C. pecorum inclusion development, we performed a preliminary experiment to determine optimal DAMP doses for inhibition of chlamydial inclusion
formation in HeLa cells. Cyclic AMP (cAMP) has not been traditionally categorized as a
DAMP, but rather an intracellular “second messenger” downstream of cell surface receptor
stimulation. However, several studies suggest that cAMP can egress from and bind receptors
on various cell types, exerting subsequent influence on cellular function (reviewed in [23]).
Furthermore, cAMP levels quickly increase in HeLa cells after ADO stimulation, and both cellpermeant and non-cell-permeant cAMP have been shown to inhibit chlamydial development
[14,24,25]. Therefore, we also evaluated the effect of cAMP on C. pecorum inclusion development, and refer to it here as a DAMP.
Cells were infected with C. pecorum at MOI 1 and the infected cells were then immediately
exposed to various concentrations of cAMP or ATP (range from 0.1 to 4 mM) or ADO (range
from 10 to 100 μM, with 25 μM EHNA) added directly to the incubation medium as a single
dose (Fig 1A). The incubation medium was allowed to remain on the infected cells until 35
hours post infection (hpi), when the cells were fixed and immunolabelled with anti-chlamydial
LPS antibodies followed by mean inclusion size determination by fluorescence microscopy (Fig
2). Inclusion size was evaluated as a measure of inhibition of inclusion development because,
in general, relatively small inclusions are considered characteristic of the chlamydial persistence/stress response (reviewed in [26]).
Exposure to cAMP reduced inclusion size in a dose dependent manner (Fig 2A). cAMP was
used at 1 mM in our subsequent experiments because this was the lowest concentration resulting in maximum inclusion size reduction to approximately 30% of control size. Exposure to
ATP caused significant reduction in inclusion size in the range of 0.5 to 4 mM concentration;
however, a typical dose dependent response was not observed (Fig 2B). Instead, relatively low
concentrations of ATP decreased inclusion size, while higher concentrations of ATP failed to
decrease inclusion size. Maximal reduction to less than 20% of control size was achieved with
1 mM ATP, and this concentration was used in subsequent experiments.
EHNA, at 25 μM, was previously shown to potentiate the anti-chlamydial activity of various
concentrations of ADO [14,27]; therefore, we evaluated the effect on inclusion size of a range
of ADO concentrations in the presence of 25 μM EHNA. Exposure to ADO to C. pecoruminfected cells reduced inclusion size in a dose dependent manner (Fig 2C). ADO at 50 μM, in
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the presence of 25 μM EHNA (EHNA/ADO), resulted in a maximal reduction to approximately 35% of control inclusion size, and was used in subsequent experiments.
Previous studies evaluating exposure of Chlamydia-infected HeLa cells to 1 mM cAMP,
ATP or ADO for 48 hours or 50 μM ADO plus 25 μM EHNA for 42 hours did not report evidence of abnormal host cell appearance or cytotoxicity [14,24]. Microscopic evidence of apoptosis caused by DAMPs, for example exposure of cultured immune cells to 1mM ATP,
includes characteristic nuclear condensation and/or fragmentation, which can be observed by
IF microscopy [28,29]. We observed no such IF microscopic evidence of abnormal nuclear
appearance upon 35 hours of exposure of C. pecorum-infected HeLa cells to any evaluated concentrations of cAMP, ATP, or EHNA/ADO. This observation is not surprising since chlamydial infection has been demonstrated to inhibit both extrinsic and intrinsic host cell apoptosis
pathways [30].

cAMP, ATP and EHNA/ADO reduce mean Chlamydia inclusion size and
number of bacteria per inclusion, but do not induce aberrant body
formation
In subsequent experiments (Fig 3), exposure of Chlamydia-infected HeLa cells to DAMPs
allowed robust infection of host cells. The addition of cAMP or ATP caused only a small, albeit
statistically significant, decrease in percent of host cells infected by C. pecorum (Fig 3A) compared to mock treatment. The percent of C. pecorum-infected cells was reduced to 34.4% by
cAMP (p = 0.0016) and to 35.2% by ATP (p = 0.0362), compared to the control infection of
39.6%. Reduction in percent of cells infected was not observed for EHNA/ADO treated C.
pecorum-infected cells (Fig 3A) or for any treated groups of C. trachomatis-infected cells (Fig
3B). The decrease in percent infection of host cells by C. pecorum in the presence of cAMP or
ATP, though statistically significant, likely represents the small size of these inclusions reducing reticle-delimited, field-based microscopic detection. Thus we expect this small reduction in
infectivity is unlikely to be biologically relevant.
Exposure to 1 mM cAMP or ATP, or 50 μM ADO in the presence of 25 μM EHNA, of C.
pecorum- or C. trachomatis-infected HeLa cells, reduced mean inclusion size (Fig 3), as
expected based on results seen in the preliminary dose experiment (Fig 2). The average C.
pecorum inclusion size was reduced to 22.0% of control with the addition of cAMP, 20.3% of
control with the addition of ATP, and 38.9% of control with the addition of EHNA/ADO (Fig
3C). Similarly, and to a larger degree, the average C. trachomatis inclusion size was reduced to
13.8% of control with the addition of cAMP, 14.0% of control with the addition of ATP, and
20.0% of control with the addition of EHNA/ADO (Fig 3D).
Immunofluorescence (IF) and transmission electron microscopy (TEM) showed that C.
pecorum (Fig 4) and especially C. trachomatis (Fig 5) inclusions exposed to DAMPs were not
only smaller, but contained sparsely distributed chlamydial bodies within the inclusions, compared to C. pecorum and C. trachomatis controls. Additionally, quantitative analysis of TEM
images indicated that exposure to DAMPs reduced the mean number of bacteria per inclusion
in C. pecorum and C. trachomatis-infected HeLa cells (Fig 6A and 6B). The mean bacteria per
C. pecorum inclusion was reduced to 19.1% of control with the addition of cAMP, 16.9% of
control with the addition of ATP, and 64% of control with the addition of EHNA/ADO,
although the reduction caused by EHNA/ADO failed to reach statistical significance (Fig 6A).
The mean bacteria per C. trachomatis inclusion was reduced, similarly and to a larger extent, to
5.8% of control with the addition of cAMP, 3.8% of control with the addition of ATP, and
12.2% of control with the addition of EHNA/ADO (Fig 6B).
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Fig 3. DAMPs reduce chlamydial inclusion size. HeLa cells were infected with C. pecorum or C. trachomatis serovar E and exposed to cAMP (1 mM),
8BrcAMP (1 mM), ATP (1 mM), apyrase (2.5 U), apyrase (2.5 U) followed by ATP (1 mM), ADO (50 μM), EHNA (25 μM), or ADO (50 μM) plus EHNA (25 μM)
in incubation medium immediately after infection. Cells were incubated for 35 hours (C. pecorum) or 39 hours (C. trachomatis), fixed and labeled with antiLPS and DAPI. Number of inclusions per nucleus was determined and percent infection was calculated for C. pecorum (A) and C. trachomatis (B)
(mean ± SD; *p  0.05, t test; n = 3). Mean inclusion size was determined for C. pecorum (C and E) and C. trachomatis (D and F) (mean ± SD; *p  0.05, t
test; n = 3).
doi:10.1371/journal.pone.0134943.g003

Cycloheximide was included in the incubation medium for experiments presented in Figs
2–6, limiting host cell de novo protein synthesis and facilitating chlamydial inclusion growth
and infectious EB production [31]. To evaluate the impact of host cell de novo protein synthesis
on DAMP-dependent modulation of inclusion development, DAMPs were added at T0, either
with or without cycloheximide supplementation of the incubation medium (S1 Fig). IF microscopy showed, as expected, that chlamydiae (S1A and S1Q Fig, C. pecorum, 90 μm2; S1I and S1S
Fig, C. trachomatis; 375 μm2) cultured in the presence of cycloheximide develop larger inclusions than do chlamydiae cultured in the absence of cycloheximide (S1E and S1R Fig, C.
pecorum, 37 μm2; S1M and S1T Fig, C. trachomatis, 131 μm2). Each DAMP significantly
reduced inclusion size compared to the control, in both chlamydial species evaluated, both in
the presence and absence of cycloheximide. However, the DAMP-dependent effect was relatively robust in the presence of cycloheximide compared to in the absence of cycloheximide.
Mean C. pecorum inclusion size was reduced, by all DAMPs evaluated, to less than 25% of control inclusion size in the presence of cycloheximide (S1A–S1D and S1Q Fig), but to less than
65% of control inclusion size in the absence of cycloheximide (S1E–S1H and S1R Fig). Similarly, mean C. trachomatis inclusion size was reduced, by all DAMPs evaluated, to less
than15% of control inclusion size in the presence of cycloheximide (S1I–S1L and S1S Fig), but
to less than 40% of control inclusion size in the absence of cycloheximide (S1M–S1P and S1T
Fig).
An increase in the presence of aberrant bodies (AB), which can be recognized by IF microscopy and TEM as abnormally large chlamydial forms within inclusions [6] (Fig 6C), was not
observed by IF microscopy upon DAMP exposure of cells infected with either C. pecorum (Fig
6D, S2A Fig) or C. trachomatis (Fig 6E, S2B Fig). TEM analyses of the mean relative proportions of EB, RB, IB (intermediate bodies, differentiating bacterial form intermediate to RB and
EB) and AB indicate that cAMP and ATP exposure, but not EHNA/ADO exposure, significantly altered the relative proportion of bacterial developmental forms (Fig 6D and 6E, S2 Fig).
Exposure of C. pecorum-infected cells (Fig 6D, S2A Fig) to cAMP and ATP reduced the proportion of EB to 6% and 2%, respectively, compared to the control proportion of 10%
(although this reduction was not statistically significant for cAMP exposure). A similar effect
was seen for C. pecorum IB, which showed a reduced proportion of 2% and 1%, upon cAMP
and ATP exposure, respectively, compared the control proportion of 6%. This was accompanied by a cAMP- and ATP-dependent increase in the proportion of C. pecorum RB to 92% and
97% respectively, compared to the control proportion of 84%. In marked contrast, exposure of
C. trachomatis-infected cells (Fig 6E, S2B Fig) to cAMP and ATP increased the proportion of
EB to 44% (for both DAMPs), compared to the control proportion of 20%; this was accompanied by a cAMP- and ATP-dependent decrease in the proportion of RB to 51% and 44%
respectively, compared to the control proportion of 72% (no effect on IB proportion was
observed). EHNA/ADO had no effect on the proportion of chlamydial developmental forms
for either species of Chlamydia evaluated (Fig 6D and 6E, S2A and S2B Fig). Electron-dense
granular material (Fig 5F) was observed by TEM in multiple inclusions of all treatment groups,
including untreated controls, of C. trachomatis-infected cells. This material appeared to be
more prevalent in DAMP-exposed C. trachomatis-infected groups than in the corresponding
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Fig 4. cAMP, ATP, and EHNA/ADO inhibit C. pecorum inclusion development without inducing
aberrant body formation. HeLa cells were infected with C. pecorum and exposed to the DAMPs cAMP
(1 mM), ATP (1 mM), or ADO (50 μM, plus 25 μM EHNA) in incubation medium immediately after infection.
Cells were incubated for 35 hours and fixed for further processing. Cells were labeled with anti-LPS (green)
and DAPI (blue) for immunofluorescence microscopic analysis (left). Cells were processed by standard
methods for transmission electron microscopic analysis (right). Representative images are shown for
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C. pecorum-infected mock- (A and B), cAMP- (C and D), ATP- (E and F), and EHNA/ADO-exposed (G and H)
cells. Immunofluorescence microscopy images represent one experiment of three independently repeated
experiments with similar results. Transmission electron microscopy images represent a single experiment.
doi:10.1371/journal.pone.0134943.g004

control group. A single incident of a similar material in an inclusion of C. pecorum-infected
cells was observed (cAMP-treated group).

The effect of ATP and ADO on Chlamydia inclusion size can be
modulated by apyrase and EHNA, respectively; the effect of cAMP can
be reproduced by cell-permeant 8BrcAMP
Modulators and analogues of the DAMPs evaluated were used to confirm that the effects
observed were attributable to these DAMPs. EHNA is an ADO deaminase inhibitor [32]. ADO
deaminase irreversibly deaminates ADO to inosine, so EHNA maintains relatively high ADO
levels by preventing its deamination, and thus helps maintain extracellular adenosine signaling.
To confirm that the inhibition of inclusion formation observed with exposure to ADO was due
to the activity of the exogenous ADO, and not activity of EHNA alone or other off-target
effects, we evaluated the effect of ADO and EHNA, separately and in combination, on Chlamydia inclusion size (Fig 3E and 3F). As expected, we found that EHNA potentiated the reduction of inclusion size by ADO in both Chlamydia species evaluated. Exposure to EHNA or
ADO alone had no significant effect on C. pecorum or C. trachomatis inclusion size.
Apyrase is an enzyme that catalyzes the hydrolysis of ATP to AMP. Thus apyrase should
reduce effects caused by action of exogenous ATP. Apyrase has previously been shown to abrogate the inhibitory effect of extracellular ATP on C. trachomatis L2 inclusion formation [27].
To confirm that the inhibitory effect on inclusion formation observed upon exposure to ATP
was due to the activity of the extracellular ATP, we evaluated the effect of apyrase on ATPdependent effects (Fig 3E and 3F). As expected, apyrase abrogated the ATP-dependent reduction of inclusion size in both Chlamydia species evaluated. In the presence of apyrase, exposure
to exogenous ATP reduced inclusion size compared to mock treated controls, but this reduction did not reach statistical significance, in contrast to exposure to ATP alone. Furthermore,
exposure of Chlamydia-infected cells to apyrase alone increased inclusion size compared to
mock treated controls, however this increase did not reach statistical significance.
Previously, cAMP levels were found to be increased in C. trachomatis L2-infected HeLa
cells, and exposure to a cell-permeant analogue of cAMP, 8-Bromo-cAMP (8BrcAMP), was
subsequently shown to have an inhibitory effect on C. trachomatis L2 inclusion formation in
HeLa cells, as measured by a reduction in relative C. trachomatis L2 16S rRNA levels [14]. This
was in contrast to a previous report that indicated exposure to cAMP, but not 8BrcAMP,
reduced inclusion size in C. trachomatis L2-infected HeLa cells [24]. We compared the effect of
cAMP and 8BrcAMP on inclusion development, as measured by mean inclusion size (Fig 3E
and 3F), and found that exposure of C. pecorum- and C. trachomatis E-infected HeLa cells to
8BrcAMP significantly reduced inclusion size compared to mock exposed controls. This was
similar to, though less dramatic than, the observed effect of non-cell-permeant cAMP.
To further confirm that DAMP exposure did not exert the effects observed by causing significant host cell death, we evaluated DAMP-exposed Chlamydia-infected HeLa cells for cell
loss from the monolayer, and mean nuclei per field was determined (S1A–S1D Fig). Exposure
of C. pecorum- or C. trachomatis-infected HeLa cells to DAMPs did not result in a reduction of
host cell nuclei numbers compared to control values. There was no evidence of cytotoxicity by
IF microscopy or TEM. Similarly, no cell loss from the monolayer was observed (S1E–S1G Fig)
at any DAMP concentration evaluated in the preliminary dose experiment (Fig 2).
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Fig 5. cAMP, ATP, and EHNA/ADO inhibit C. trachomatis inclusion development without inducing
aberrant body formation. HeLa cells were infected with C. trachomatis serovar E and exposed to the
DAMPs cAMP (1 mM), ATP (1 mM), or ADO (50 μM, plus 25 μM EHNA) in incubation medium immediately
after infection. Cells were incubated for 39 hours and fixed for further processing. Cells were labeled with antiLPS (green) and DAPI (blue) for immunofluorescence microscopic analysis (left). Cells were processed by
standard methods for transmission electron microscopic analysis (right). Representative images are shown
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for C. trachomatis-infected mock- (A and B), cAMP- (C and D), ATP- (E and F), and EHNA/ADO-exposed (G
and H) cells. Immunofluorescence microscopy images represent one experiment of three independently
repeated experiments with similar results. Transmission electron microscopy images represent a single
experiment.
doi:10.1371/journal.pone.0134943.g005

cAMP, ATP, and EHNA/ADO reversibly reduce chlamydial inclusion size
and infectivity in a species-specific manner
To evaluate the impact of DAMP exposure of Chlamydia-infected cells on subsequent infectious EB production, infected and exposed cells were collected and subjected to freeze/thaw
and sonication to lyse cells and release EB. These samples were then used to re-infect HeLa
cells, and inclusion forming units (IFU) per ml were determined (Fig 7A and 7B). As expected,
based on the marked reduction in inclusion size upon DAMP exposure of Chlamydia-infected
cells (Fig 3C and 3D), and the reduction of bacteria per inclusion associated with this reduction
in inclusion size (Fig 6A and 6B), IFU/ml was significantly reduced in all DAMP exposed
groups, compared to the control exposed group, for both C. pecorum (Fig 7A) and C. trachomatis E (Fig 7B). cAMP, ATP, and EHNA/ADO exposure reduced IFU/ml to less than 1% of
the control in all DAMP-exposed C. pecorum-infected cells (Fig 7A), to less than 1% of the control in cAMP and EHNA/ADO-exposed C. trachomatis-infected cells, and to less than 3% of
the control in ATP-exposed C. trachomatis-infected cells (Fig 7B). Notably, though DAMP
exposure decreased chlamydial infectious EB production by at least 97% (Fig 7), reduction in
inclusion size ranged from only approximately 61% to 86% of control values for both species
tested (Fig 3), suggesting that there is not a strong correlation between inclusion size and infectious EB production.
Cycloheximide was included in the incubation medium for the experiment presented in Fig
7A and 7B, and consequently the marked DAMP-dependent reduction of infectious EB production for both chlamydial species tested occurred specifically under the condition of limited
host cell de novo protein synthesis. To investigate the impact of this restriction on the observed
DAMP-dependent anti-chlamydial effect, DAMPs were added at T0, either with or without
cycloheximide supplementation of the incubation medium, and processed to determine infectious EB production, presented as IFU/ml (S4 Fig). In contrast to the similar, but less substantial, DAMP-dependent reductive effect on inclusions size noted in the absence of
cycloheximide versus the presence of cycloheximide (S1 Fig), reduction, and even reversal, of
the DAMP-dependent reductive effect on infectious EB production was observed in the
absence of cycloheximide versus the presence of cycloheximide (S4 Fig). C. pecorum IFU/ml, as
expected, was reduced to less than 1% of the control IFU/ml by all DAMPs evaluated in the
presence of cycloheximide (S4A Fig). However, in the absence of cycloheximide, EHNA/ADO
exposure reduced C. pecorum IFU/ml to only 73.5% of the control IFU/ml, while cAMP and
ATP exposure increased C. pecorum IFU/ml to 311.2% and 271.8%, respectively (S4B Fig). C.
trachomatis IFU/ml, was reduced to less than 1% of the control IFU/ml, in the presence of
cycloheximide, upon exposure to all DAMPs evaluated (S4C Fig). In the absence of cycloheximide, however, C. trachomatis IFU/ml was reduced to 12.4% of control by EHNA/ADO, not
significantly changed by cAMP (though a reduction to 74.6% of control IFU/ml closely
approached, but did not reach, significance; p = 0.0540) and increased to 163.3% of control by
ATP (S4D Fig).
Previous reports indicate that cAMP, ATP, or EHNA/ADO cause reversible inhibition of C.
trachomatis (serotypes L2 and/or D) inclusion development in HeLa cells [14,24,27]; while
ATP-induced inhibition of Chlamydia (C.) muridarum or C. psittaci inclusion development in
macrophages has not been described as reversible [11–13]. To determine if the anti-chlamydial
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Fig 6. cAMP, ATP and EHNA/ADO reduce the number of bacteria per inclusion. HeLa cells were infected with C. pecorum or C. trachomatis serovar E
and exposed to the DAMPs cAMP (1 mM), ATP (1 mM), or ADO (50 μM, plus 25 μM EHNA) in incubation medium immediately after infection. Cells were
incubated for 35 hours (C. pecorum) or 39 hours (C. trachomatis), fixed, and processed by standard methods for TEM analysis. Total number of bacteria (EB,
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IB, RB, and AB) in ten inclusions per condition was determined, and mean number of bacteria per inclusion (A and B) was calculated (mean ± SD;
*p  0.0001, t test; n = 10 inclusions from a single experiment). A representative image of an inclusion in mock-exposed, C. trachomatis-infected cells (C)
shows EB (dark, 0.25–0.5 μm), IB (dark center and pale periphery), RB (pale, 0.5–1 μm) and AB (pale, <2 μm). Analyses of the mean relative proportion of
EB, RB, IB and AB per each experimental group are shown for C. pecorum (D) and C. trachomatis (E).
doi:10.1371/journal.pone.0134943.g006

effects of DAMPs observed here in C. pecorum- and C. trachomatis-infected HeLa cells are
reversible, we repeated the 35 and 39 hour exposure of C. pecorum- and C. trachomatis E
infected-HeLa cells to DAMPs, then changed the incubation medium, replacing it with either
incubation medium alone (recovery condition) or incubation medium containing cAMP, ATP,
or EHNA/ADO (continued exposure condition; using same concentrations as initial 35–39
hour exposures) and incubated the infected cells a further 24 hours (Fig 1C).
IF microscopic analysis of C. pecorum-infected cells (Fig 8) demonstrated that, for all
DAMP-exposed groups (Fig 8D–8L), excluding the mock-exposed control (Fig 8A–8C), inclusions increased in size from 35 hpi (Fig 8 left) to 24 hours later (59 hpi), despite continued
exposure to DAMPs (Fig 8 middle). Mock-exposed cells, as expected, were almost entirely lost
from the coverslip monolayer by 59 hpi (Fig 8B and 8C). The apparent density of bacteria
within the C. pecorum inclusions, reduced by the initial 35-hour exposure to cAMP, ATP or
EHNA/ADO, however, did not substantially increase visibly upon 24 hours of continued
exposure.
In contrast, in C. pecorum-infected cells exposed to cAMP or ATP for 35 hours then allowed
to recover in the absence of DAMPs for 24 hours (Fig 8F and 8I), both the size and visible bacterial density of inclusions increased substantially compared to similar infected cells subjected
to continued DAMP exposure (Fig 8E and 8H). However, C. pecorum-infected cells exposed to
EHNA/ADO for 35 hours then allowed to recover in the absence of DAMPs for 24 hours (Fig
8L) showed marked cell loss, apparently ruptured inclusions and abundant extracellular chlamydial bodies, making comparison of inclusion size upon continued DAMP exposure versus
recovery unreliable in EHNA/ADO-exposed C. pecorum-infected cells. Furthermore, C.
pecorum-infected, EHNA/ADO-exposed cells were also lost from the monolayer after 24 hours
of continued exposure following the initial 35-hour exposure, and extracellular chlamydial
bodies were apparent (Fig 8K).
In mock-exposed C. trachomatis-infected cells, less marked cell loss from the monolayer
was observed upon 24 hours of additional culture after 39 hpi than was observed for corresponding mock-exposed C. pecorum-infected cells (Fig 9B and 9C). However, burst cells and
cell fragments adherent to the host cell monolayer surface were visible on all areas of the coverslip (fluorescent signal from the nuclei can be seen, Fig 9B and 9C). In C. trachomatis-infected
HeLa cells, for all DAMP exposure groups, including the mock-exposed control, inclusions
also increased in size between 39 hpi (Fig 9 left) and 24 hours later despite continued DAMP
exposure (Fig 9 middle). However, as noted for C. pecorum (Fig 8), the density of bacteria
within the C. trachomatis inclusions, reduced by the initial 39-hour exposure to cAMP, ATP or
EHNA/ADO (Fig 9 left), did not substantially increase upon 24 hours of continued DAMP
exposure (Fig 9 middle). In contrast, in C. trachomatis-infected cells exposed to cAMP, ATP or
EHNA/ADO for 39 hours then allowed to recover in the absence of DAMP exposure for 24
hours (Fig 9 right), both the size and visual bacterial density of inclusions increased substantially compared to similar infected cells subjected to continued DAMP exposure (Fig 9 middle),
although EHNA/ADO-exposed infected cells showed a more pronounced recovery of bacterial
density within the inclusions than cAMP- or ATP-exposed cells.
In both C. pecorum- and C. trachomatis-infected cells, for all experimental groups some cell
loss was seen upon 24 hours of continued incubation, regardless of continued DAMP exposure
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Fig 7. DAMPs reversibly reduce chlamydial infectivity in a species-specific manner. HeLa cells were infected with C. pecorum or C. trachomatis
serovar E and exposed to cAMP (1 mM), ATP (1 mM), or ADO (50 μM, plus 25 μM EHNA) in incubation medium immediately after infection and incubated for
35 hours (C. pecorum) or 39 hours (C. trachomatis). Infected monolayers were then collected and processed for titration by sub-passage. Number of
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inclusions was determined and inclusion forming units (IFU) per ml (IFU/ml) was calculated for C. pecorum (A) and C. trachomatis (B) (mean ± SD;
*p  0.05, t test; n = 3). In some wells, incubation medium on cells was replaced with fresh incubation medium with DAMPs for continued exposure or without
DAMPs for recovery. These cells were incubated a further 24 hours before processing for titration by sub-passage. Number of inclusions was determined and
IFU/ml was calculated for C. pecorum (C) and C. trachomatis (D) (mean ± SD, *p  0.05, t test; values are derived from duplicate determinations within a
representative experiment, and represent results obtained from two independent experiments).
doi:10.1371/journal.pone.0134943.g007

or recovery conditions. However, in all cases, cell loss was greater under recovery conditions
than under continued DAMP exposure conditions (Figs 8 and 9), suggesting that continued
infection, not continued exposure, is responsible for the observed cell loss. Because the cells

Fig 8. cAMP, ATP and EHNA/ADO reversibly reduce C. pecorum inclusion size. HeLa cells were
infected with C. pecorum (A-L) and exposed to cAMP (1 mM; D-F), ATP (1 mM; G-I), or ADO (50 μM, plus
25 μM EHNA; J-L) in incubation medium immediately after infection and incubated for 35 hours (A-C = mock
exposed). At 35 hours post infection cells were fixed and labeled with anti-LPS (green) and DAPI (blue) (left).
In replicate wells, incubation medium on cells was replaced with fresh incubation medium with DAMPs for
continued exposure (middle) or without DAMPs for recovery (right). These cells were incubated a further 24
hours before fixation and labeling with anti-LPS and DAPI. Images represent one experiment of two
independently repeated experiments with similar results.
doi:10.1371/journal.pone.0134943.g008
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Fig 9. cAMP, ATP and EHNA/ADO reversibly reduce C. trachomatis inclusion size. HeLa cells were
infected with C. trachomatis serovar E (A-L) and exposed to cAMP (1 mM; D-F), ATP (1 mM; G-I), or ADO
(50 μM, plus 25 μM EHNA; J-L) in incubation medium immediately after infection and incubated for 39 hours
(A-C = mock exposed). At 39 hours post infection cells were fixed and labeled with anti-LPS (green) and
DAPI (blue) (left). In replicate wells, incubation medium on cells was replaced with fresh incubation medium
with DAMPs for continued exposure (middle) or without DAMPs for recovery (right). These cells were
incubated a further 24 hours before fixation and labeling with anti-LPS and DAPI. Images represent one
experiment of two independently repeated experiments with similar results.
doi:10.1371/journal.pone.0134943.g009

and inclusions remaining may or may not accurately represent inclusion size for an entire coverslip, quantitative measurements were not carried out in these experiments. Thus, results presented are based on qualitative observations of approximately 20 1000x oil-immersion fields
per coverslip and images are representative of similar results observed in two independent
experiments.
To evaluate the impact of continued DAMP exposure or recovery conditions on subsequent
infectious EB production in DAMP-exposed, Chlamydia-infected cells, in light of the observed
differential cell loss between mock-exposed and DAMP-exposed groups, cells and culture
supernatants were collected after 35- or 39-hour exposure to DAMPs followed by 24 hours of
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continued exposure or recovery. To accurately represent total infectious EB, both released into
the supernatant and retained within intact inclusions and cells, the collected cell culture supernatant was combined with collected cells for each sample. These samples were subjected to
freeze/thaw and sonication to release EB, used to re-infect HeLa cells, and IFU/ml was determined (7 C and D).
As expected, based upon the microscopically observed increases in inclusion size and bacterial density upon recovery from cAMP and ATP exposure of C. pecorum-infected cells (Fig 8F
and 8I) compared to C. pecorum-infected cells continuously exposed to these DAMPs (Fig 8E
and 8H), IFU/ml was increased in these recovery groups, compared to the correlating continuously exposed groups (Fig 7C). Additionally, EHNA/ADO-exposed C. pecorum-infected cells
also showed an increase in IFU/ml in recovery versus continuous exposure groups (Fig 7C),
suggesting that the increased cell loss observed microscopically for the EHNA/ADO recovery
group (Fig 8L) compared to the continuously exposed group (Fig 8K) was due to relatively
more robust chlamydial growth.
In contrast to the results seen for C. pecorum (Fig 8), although C. trachomatis inclusions
showed comparatively increased size and visible bacterial density upon recovery from cAMP,
ATP, and EHNA/ADO exposure (Fig 9), a concomitant increase in IFU/ml was seen only in
the EHNA/ADO-exposed group (Fig 7D). This suggests that the inclusions in cAMP- and
ATP- exposed groups (Fig 9) may not produce infectious EB after 24 hours of recovery, despite
a relatively normal IF microscopic appearance. This is also in agreement with the lack of close
correlation between reduced inclusion size (Fig 3C and 3D) and reduced IFU/ml (Fig 7A and
7B) previously discussed.

cAMP, ATP, and EHNA/ADO similarly, though less dramatically, reduce
inclusion size when Chlamydia-infected cells are exposed at 14 hpi
versus 0 hpi
Previously, we have shown that PEDV reversibly reduces productive development of both C.
pecorum and C. abortus and results in conspicuous AB formation, features consistent with
chlamydial persistence/stress [6]. Because PEDV-dependent induction of these effects occurred
upon exposure of Chlamydia-infected host cells to PEDV at 14 hours post chlamydial infection, we postulated whether the timing of exposure to the persistence inducer might exert an
influence on the microscopic appearance of the chlamydial inclusions, with regard to AB formation. Thus we evaluated the effect exposure of Chlamydia-infected cells to DAMPs at 14 hpi
(Figs 1B and 10).
Exposure of C. pecorum-infected (Fig 10A) and C. trachomatis-infected (Fig 10G) cells to
DAMPs at 14 hpi had no effect on percent of host cells infected. Inclusion size was reduced by
14 hpi DAMP exposure of C. pecorum-infected (Fig 10B) and C. trachomatis-infected (Fig
10H) cells, although the degree of this reduction was less pronounced than that observed for
such exposure immediately post infection (Fig 3C and 3D). C. pecorum mean inclusion size
was reduced to 49.8% of control with the addition of cAMP, 61.5% of control with the addition
of ATP, and 70.9% of control with EHNA/ADO at 14 hpi (Fig 10B). C. trachomatis mean
inclusion size was reduced to 37.5% of control with the addition of cAMP, 43.4% of control
with the addition of ATP, and 45.6% of control with EHNA/ADO at 14 hpi (Fig 10H).
The appearance, by IF microscopy, of C. pecorum (Fig 10C–10F) and C. trachomatis (Fig
10I–10L) in cells treated with DAMPs at 14 hpi was similar to that seen upon exposure of
infected cells immediately post infection (Figs 4 and 5), and, as for earlier exposure no increase
in the presence of AB within the inclusions was noted. As observed in similar exposure of
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Fig 10. cAMP, ATP and EHNA/ADO inhibit inclusion development less dramatically when added at 14 hpi. HeLa cells were infected with C. pecorum
or C. trachomatis serovar E and exposed to 1 mM cAMP, 1 mM ATP, or 50 μM ADO plus 25 μM EHNA in incubation medium 14 hours after infection. Cells
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were fixed and labeled with anti-LPS (green) and DAPI (blue) at 35 hours post infection (C. pecorum) or 39 hours post infection (C. trachomatis). Number of
inclusions per nucleus was determined and percent infection was calculated for C. pecorum (A) and C. trachomatis (G) (mean ± SD; p > 0.05 in all cases, t
test; n = 3). Mean inclusion size was determined for C. pecorum (B) and C. trachomatis (H) (mean ± SD; *p  0.05, t test; n = 3). Representative images are
shown for C. pecorum-infected mock- (C), cAMP- (D), ATP- (E), and EHNA/ADO-exposed (F) cells and for C. trachomatis-infected mock- (I), cAMP- (J),
ATP- (K), and EHNA/ADO-exposed (L) cells. Immunofluorescence microscopy images represent one experiment of three independently repeated
experiments with similar results.
doi:10.1371/journal.pone.0134943.g010

Chlamydia-infected host cells with DAMPs added immediately after infection, exposure at 14
hpi did not result in host cell loss from the monolayer (S3H and S3I Fig).

Discussion
In summary, the present study reports that DAMPs, including extracellular ATP and adenosine, and cyclic AMP, which posses extracellular signaling capabilities, inhibit Chlamydia
pecorum inclusion development in vitro in the absence of de novo host cell protein synthesis.
Under host protein synthesis limitations, each of these DAMPs induce similar alterations of
the C. pecorum developmental cycle and, in the case of adenosine, of the C. trachomatis serotype E developmental cycle, to those previously reported for C. caviae, C. muridarum and C.
trachomatis serotypes D and L2 [11,12,14,27]. These changes include (i) reduction in inclusion
size and bacterial density within inclusions, without AB formation; (ii) reduction in release of
infectious EB; and (iii) recovery of infectious EB production upon removal of DAMP stimulus.
The latter two changes are consistent with the currently accepted definition of persistence or
the chlamydial stress response, namely viable, but non-infectious chlamydiae; while lack of
aberrant body formation is atypical in chlamydial persistence, but not entirely unrepresented
[26]. For example, iron deprivation reduced C. trachomatis inclusion size without inducing AB
formation, though RB morphology was affected, exhibiting wavy cell membranes on the normal-sized RB (determined by electron microscopic analysis) [33]. While in interferon-dependent persistence/chlamydial stress induction, host cell species determines a difference in AB
formation, with AB formation associated with human host cell lines [26,34] but not with
murine cell lines [34,35]. Notably, C. trachomatis serotype E failed to recover infectious EB
production within 24 hours after discontinuation of cAMP or ATP exposure, an effect which
can be explained as killing of the chlamydiae, rather than persistence induction. Further evaluation of possible recovery over extended times may reveal whether C. trachomatis serotype E is
incapable of recovery from cAMP or ATP exposure under certain experimental conditions, or
whether species-specific differences exist in the timing of recovery of chlamydiae from
DAMPs.
Importantly, the evaluation of inhibition of inclusion development and subsequent recovery
from DAMPs reported here was evaluated in the presence of cycloheximide, and thus conclusions about species-specific differences in inhibition by DAMPs and recovery from DAMPs
must be made in the context of significantly reduced or abolished host cell de novo protein synthesis. In fact, as determined specifically by parallel evaluation of DAMPs exposure in the presence or absence of cycloheximide, in the absence of cycloheximide, cAMP and ATP exposure
elicited a markedly different effect on infectious EB production, compared to exposure in the
presence of cycloheximide, in both species of chlamydiae tested. In the presence of cycloheximide, both species showed dramatic cAMP- and ATP-dependent reductions in infectious EB
production. However, in the absence of cycloheximide, this effect was reversed for C. pecorum,
which showed cAMP- and ATP-dependent increases in infectious EB production. Likewise,
the effect was reversed for C. trachomatis upon ATP exposure, and reduced to statistical similarity with the control upon cAMP exposure. EHNA/ADO exposure, however, elicited a reduction in IFU/ml compared to the control both in the presence or absence of cycloheximide for
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both chlamydial species evaluated, though a more marked reduction was observed in the presence of cycloheximide for both species. Interestingly, the reductive effect on inclusion size
observed for all DAMPs and both chlamydial species in the presence of cycloheximide was also
observed in the absence of cycloheximide, though, again, to a lesser extent.
The fluorescence and electron microscopic analysis reported here confirms that viable but
non-infectious chlamydiae may be induced upon exposure to DAMPs in culture, but such
stressed RB need not be enlarged and irregularly shaped to exhibit the observed reversible
reduction in chlamydial infectivity. In fact, the conspicuous reduction in bacterial numbers,
with no obvious alterations to EB or RB microscopic appearance suggests that DAMP-induced
chlamydial biological changes, though currently unknown, markedly differ from reported
changes associated with other persistence inducers such as antibiotic exposure, cytokine exposure, or viral co-infection. For example, smaller-sized inclusions, populated exclusively with
grossly enlarged AB, were previously seen in PEDV-induced aberrant C. pecorum inclusion
morphology [6]. In the current study, we evaluated the effect on inclusion formation when
cAMP, ATP, or EHNA/ADO were added at 14 hpi, specifically to address the possibility that
the time after chlamydial infection of exposure to an inducer of persistence/chlamydial stress
might influence AB production. However, DAMPs added at 14 hpi, compared to 0 hpi, also
failed to induce AB formation, and instead exerted an effect on chlamydial inclusion development equivalent, if somewhat less dramatic, to that seen at 0 hpi exposure. This indicates that
the inducer of aberrant chlamydial inclusions, not the time of induction, is responsible for the
disparate appearance of aberrant inclusions in Chlamydia-infected cells treated with cAMP,
ATP, or EHNA/ADO versus those exposed to PEDV. Furthermore, this suggests that while
release of DAMPs from PEDV-infected cells may influence the C. pecorum developmental
cycle, the AB formation and persistence/chlamydial stress observed in the previously reported
C. pecorum/PEDV co-infection model is not likely to be entirely ATP-, cAMP-, or EHNA/
ADO-dependent.
One may speculate that the apparent bacterial morphology difference in DAMP-induced
persistence/chlamydial stress represents a fundamentally different mode of action than that
effecting AB-associated persistence/chlamydial stress. The phenomenon of interferon-induced
persistence/chlamydial stress has been well studied, and it is known that interferon elicits its
effects on chlamydiae dissimilarly in human versus murine host cells. In human cells the primary effector of persistence is indoleamine dioxygenase (IDO), the activation of which depletes
host intracellular tryptophan levels needed for chlamydial growth; while in murine cells, persistence is induced in the absence of IDO activation and can involve nitric oxide synthase (NOs)
activation, lipid acquisition disruption, or increased fusion of inclusions with lysosomes
[34,36]. The mechanisms for virus co-infection-induced persistence/chlamydial stress was
demonstrated to be imbalanced oxidative stress in the case of human herpes virus 6 [5]. In contrast, herpes simplex virus type-2 mediated down-regulation of host nectin-1 protein appears
to induce C. trachomatis persistence [37]. The involvement of these modes of action has not
yet been investigated in the context of DAMP-induced persistence/chlamydial stress, and currently, evaluation of possible modes of action for DAMP-induced persistence/chlamydial stress
has been limited.
In a study in which cAMP was shown to reversibly reduce chlamydial inclusion size and
infectivity, reduction in EB-specific antigens was noted in cAMP-exposed C. trachomatis, suggesting to the authors that cAMP exerted its effect on C. trachomatis by arresting development
at the RB stage, though no mode of action was proposed [24]. In an earlier study that reported
inhibition of C. trachomatis infectivity in HeLa cells exposed to cell-permeant cAMP before
infection, pretreatment with an ionophore which selectively increases the level of intracellular
calcium abolished the anti-chlamydial effect of cAMP. However, a reduction in intracellular
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calcium was not demonstrated upon cAMP exposure, though an increase in calcium mobilization was noted upon chlamydial infection alone [25].
The effects of extracellular ATP on chlamydial persistence/stress in various cell types has
been demonstrated, in a series of several studies, to act via the P2X7 receptor both in vitro and
in a murine infection model, and under some conditions the P2X4 receptor was also shown to
play a role in persistence induction [11–13,27]. In both macrophages and HeLa cells, ATP signaling via the P2X7 receptor was demonstrated to act at least in part via phospholipase D activation; in the case of macrophages this was associated with lysosome/vacuole fusion [12,13].
Finally, extracellular adenosine-dependent induction of chlamydial persistence/stress was
shown to act via A2b receptor stimulation, and although this was demonstrated to be cAMPdependent protein kinase (PKA)-independent, the authors noted that both cell-permeant and
non-permeant cAMP exerted a similar effect as adenosine and postulated that cAMP is downstream of adenosine signaling and might be responsible for the observed effects [14]. Notably,
adenosine-dependent induction of chlamydial persistence/stress was reported to occur in both
the presence and absence of cycloheximide, leading the authors to conclude that de novo host
cell protein synthesis was not required for the observed effects of adenosine [14]. Likewise, the
data reported here, in which cycloheximide was included in the incubation medium and
remained on the cells for the duration of the experiments, further supports the previous findings and conclusion. Furthermore, we can conclude from parallel evaluation of the effects of
DAMPs in the presence/absence of cycloheximide, that extracellular adenosine can exert similar anti-chlamydial effects in the absence or presence of new host cell protein synthesis, while
anti-chlamydial effects of cAMP and ATP are abolished, or even reversed, when host cells have
uninhibited protein synthesis capabilities.
The marked DAMP-dependent reductions in inclusion size and infectious EB production
demonstrated for both C. pecorum and C. trachomatis, were accompanied by changes in the
relative proportion of the different chlamydial developmental forms within TEM-observed
inclusions. Interestingly, the specific changes effected in these relative proportions were starkly
different in the two chlamydial species. C. pecorum exhibited an increase in the proportion of
RB, and a concomitant decrease in the proportion of EB, upon exposure to cAMP or ATP. In
contrast, C. trachomatis exhibited the opposite effect: a decrease in the proportion of RB, and a
concomitant increase in the proportion of EB, upon cAMP or ATP exposure. This might offer
an explanation for the ability of C. pecorum, but not C. trachomatis, to recover from cAMP or
ATP exposure under the experimental conditions evaluated. Notably dissimilar to cAMP and
ATP, EHNA/ADO did not effect changes in the relative proportions of RB and EB for either
chlamydial species.
Though the current study does not specifically address possible mechanisms of persistence
induction, we do not expect that the pronounced effect of DAMPs on chlamydial inclusion
development is due to marked host cell death or damage, since microscopically (IF and TEM)
host cells appeared unaltered by any DAMP exposure up to 39 hours post chlamydial infection.
In support of this, the exposure of C. trachomatis L2-infected HeLa cells to 1 mM cAMP has
previously been reported to inhibit normal inclusion development, with no indicated observation of cytotoxicity or cell loss upon 48 hours of treatment [24]. Additionally, the addition of
25 μM EHNA/ 50 μM ADO to C. trachomatis L2- and C. trachomatis D-infected HeLa cells
was previously shown to inhibit chlamydial inclusion development, and cytotoxic effects were
not reported [14]. In contrast, extracellular ATP, at concentrations including 1 mM, is well
known to induce apoptosis in various cell types, particularly immune cells and transformed
cells, and causes a characteristic microscopic appearance including reduced cell surface microvilli, shrunken cells with increased membrane blebbing, and nuclear condensation and/or fragmentation [28,29]. However, we observed no signs of ATP-induced cytotoxicity at any
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concentration evaluated (by fluorescence or electron microscopy). In support of this finding,
(i) previous studies have indicated cycloheximide (used at 1 μg/ml in incubation medium in all
experiments shown here) abrogates the morphological effects of ATP-induced apoptosis [28];
(ii) HeLa cells are resistant to extracellular ATP-induced apoptosis, a characteristic thought to
be attributable to expression of high levels of a truncated purinergic receptor (P2X7) [13] and/
or expression of human papillomavirus oncogenes that may offer additional protection against
apoptosis [38]; and, finally, (iii) Chlamydia-infected cells, including epithelial cells, are protected against induced apoptosis [39].
Data from this study shows that C. trachomatis, which exhibits no significant recovery in
infectious EB production after cAMP or ATP exposure, appears to be more sensitive to
DAMPs than C. pecorum, which significantly recovered infectious EB production after exposure to these molecules, suggesting that species-specific difference exist in the degree of chlamydial response to DAMPs. Both chlamydial species, however, recovered significantly after
exposure to ADO, indicating that all DAMPs evaluated in this study might not be exerting an
identical effect on the chlamydiae. Additionally, our data suggest that cAMP can exert a similar
effect whether or not the molecule is cell-permeant, however, we cannot rule out some entry
into the host cells of non-cell-permeant cAMP, making it unclear whether or not cAMP and
8BrCAMP are acting via a shared or distinct mechanism. Also, we showed that exposure of C.
pecorum-infected cells to apyrase alone, an enzyme that catalyzes the hydrolysis of ATP, added
in the absence of addition of exogenous ATP, increased inclusion size compared to mock
treated controls, though this reduction did not reach statistical significance. This suggests that
apyrase reduces levels of endogenous ATP, which thus may be expected to limit chlamydial
development during the course of infection, at least in vitro.
We also report that infectious EB production in DAMP-exposed chlamydiae does not in all
cases correlate well with inclusion size or mean bacteria per inclusion. For example, in the presence of cycloheximide, C. pecorum showed a greater than 99% decrease in the production of
infectious EB upon exposure to EHNA/ADO, despite the fact that corresponding mean bacteria per inclusion was reduced by only 36%, suggesting that microscopically typical-appearing
bacteria were in fact non-infectious after exposure to DAMPs. Because, in the absence of cycloheximide, cAMP- and ATP-dependent reduced chlamydial inclusion size still failed to correlate with reduced infectious EB production, we can conclude that, both in the presence and
absence of de novo host protein synthesis, inclusion size is not a good measure of infectious EB
production in all cases. This is in agreement with a recent report indicating that chlamydial
protein synthesis, but not chlamydial replication, is required for normal expansion of C. trachomatis inclusions [40]. It can thus be speculated that the DAMP-dependent reduction of
inclusion size observed for C. pecorum and C. trachomatis serotype E occurs, in part, independently of host cell de novo protein synthesis, and may result from mechanisms requiring bacterial protein synthesis. In contrast, the cAMP- and ATP-dependent reduction of infectious EB
release by the chlamydial species evaluated appears to depend on inhibited host cell protein
synthesis.
Recovery, as expected, appears to depend upon the re-entry of chlamydiae into the normal
developmental cycle, since the two groups that did not recover within 24 hours of discontinuation of DAMP-exposure, namely C. trachomatis exposed to cAMP or ATP, showed a reduction
in mean bacteria per inclusion of at least 94%, more in line with the infectious EB reduction.
This additionally supports the idea that DAMPs may induce persistence under some circumstances but may cause irreversible inhibition (killing) of chlamydial development under other
circumstances. In conclusion, while the mechanisms responsible for DAMP-dependent chlamydial persistence/stress remain to be elucidated, the data presented here, along with that of
previous studies evaluating DAMP-induced persistence/chlamydial stress, suggests damage/
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danger signaling may play a significant role in the host/pathogen interactions that regulate
chlamydial infections. In vivo concentrations of the evaluated DAMPs vary, but are generally
relatively low. Intracellular ATP levels are typically in the 3–10 mM range, with extracellular
levels rising into the hundreds of μM range under physiological stress [41]. Adenosine tissue
levels are normally in the nM range, but may rise as high as 100 μM in inflamed/ischemic tissues [42]. Normal physiological cAMP levels approach the μM range, however, broad variations in cAMP levels induced by various stimuli in various tissues are of unknown biological
importance [43]. Because lysis of host cells during Chlamydia infection, and various other
infections, has the potential to markedly increase local concentrations of DAMPs at the site of
infection, DAMPs may play a role in the progression of Chlamydia infection in vivo, particularly in the context of poly-microbial infections.

Supporting Information
S1 Fig. DAMPs reduce inclusion size in the presence or absence of new host cell protein
synthesis. HeLa cells were infected with C. pecorum (A-H, Q-R) or C. trachomatis serovar E
(I-P,S-T) and exposed to the DAMPs cAMP (1 mM), ATP (1 mM), or ADO (50 μM, plus
25 μM EHNA) in incubation medium, in the presence (A-D, I-L, Q, S) or absence (E-H, M-P,
R, T) of 1 μg/ml cycloheximide, immediately after infection. Cells were incubated for 35 hours
(C. pecorum) or 39 hours (C. trachomatis), fixed and labeled with anti-LPS and DAPI, and
inclusion size was determined (mean ± SD;  p  0.0002, t test; n = 50 inclusions per coverslip
from a single experiment).
(TIFF)
S2 Fig. cAMP and ATP modulate the proportion of chlamydial developmental forms
within inclusions. HeLa cells were infected with C. pecorum or C. trachomatis serovar E and
exposed to the DAMPs cAMP (1 mM), ATP (1 mM), or ADO (50 μM, plus 25 μM EHNA) in
incubation medium immediately after infection. Cells were incubated for 35 hours (C. pecorum)
or 39 hours (C. trachomatis), fixed, and processed by standard methods for TEM analysis. Total
number of bacteria (EB, RB, IB, and AB) in ten inclusions per condition was counted, the proportion of each bacterial type per inclusion was determined, and mean proportion of developmental
forms for the 10 inclusions per experimental group were calculated (mean ± SD;  p = 0.05, t test;
n = 10 inclusions from a single experiment). The relative proportions of EB, RB, IB and AB are
shown for C. pecorum (A) and C. trachomatis (B).
(TIFF)
S3 Fig. cAMP, ATP and EHNA/ADO do not cause host cell loss. HeLa cells were infected
with C. pecorum or C. trachomatis serovar E and exposed to cAMP (1 mM), 8BrcAMP (1 mM),
ATP (1 mM), Apyrase (2.5 U), Apyrase (2.5 U) followed by ATP (1 mM), ADO (50 μM),
EHNA (25 μM), or ADO (50 μM) plus EHNA (25 μM) in incubation medium immediately
after infection (T0; A-G) or 14 hours post infection (T14; H,I). Cells were incubated for
35 hours (C. pecorum) or 39 hours (C. trachomatis) from T0, then fixed and labeled with antiLPS and DAPI. Number of nuclei was determined and mean nuclei per field was calculated
(mean ± SD; p >0.05 in all cases, t test; n = 3 A-D and H-I, n = 8 fields per coverslip from a single experiment E-G).
(TIFF)
S4 Fig. DAMP-dependent modulation of infectious EB production depends on host cell de
novo protein synthesis. HeLa cells were infected with C. pecorum (A-B) or C. trachomatis serovar E (C-D) and exposed to the DAMPs cAMP (1 mM), ATP (1 mM), or ADO (50 μM, plus
25 μM EHNA) in incubation medium, in the presence (A, C) or absence (B, D) of 1 μg/ml
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cycloheximide, immediately after infection. Cells were incubated for 35 hours (C. pecorum) or
39 hours (C. trachomatis). Infected monolayers were then collected and processed for titration
by sub-passage. Number of inclusions was determined and inclusion forming units (IFU) per
ml was calculated (mean ± SD,  p  0.05, t test; values are derived from duplicate determinations within a single experiment).
(TIFF)
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